Zobrazeno 1 - 10
of 297
pro vyhledávání: '"Watek M"'
Autor:
Macauda A; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Briem K; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Clay-Gilmour A; Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA., Cozen W; Division of Hematology/Oncology, Division of Hematology/Oncology, Department of Medicine, School of Medicine, Department of Pathology, School of Medicine, Susan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California at Irvine, Irvine, CA, USA., Försti A; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Giaccherini M; Department of Biology, University of Pisa, Pisa, Italy., Corradi C; Department of Biology, University of Pisa, Pisa, Italy., Sainz J; Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS, Granada, Spain.; Instituto de Investigación Biosanitaria IBs.Granada, Granada, Spain.; Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain., Niazi Y; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Ter Horst R; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Li Y; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.; Centre for Individualised Infection Medicine (CiiM) & TWINCORE, joint ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany., Netea MG; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.; Department for Immunology & Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany., Vogel U; National Research Centre for the Working Environment, Copenhagen, Denmark., Hemminki K; Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, Czech Republic.; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Slager SL; Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Varkonyi J; Department of Hematology, Semmelweis University, Budapest, Hungary., Andersen V; Molecular Diagnostics and Clinical Research Unit, Institute of Regional Health Research, University Hospital of Southern Denmark, Odense, Denmark.; Institute of Regional Research, University of Southern Denmark, Odense, Denmark.; Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Iskierka-Jazdzewska E; Department of Hematology, Transplantology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland., Mártinez-Lopez J; Hospital Universitario 12 de Octubre, Instituto de Investigación del Hospital Universitario 12 de Octubre, 28041, Madrid, Spain., Zaucha J; Department of Haematology & Transplantology, Medical University of Gdańsk, Gdańsk, Poland., Camp NJ; Division of Hematology and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Druzd-Sitek A; Department of Lymphoproliferative Diseases, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Bhatti P; Cancer Control Research, BC Cancer, Vancouver, BC, Canada.; Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kumar SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Subocz E; Department of Hematology, Warmian-Masurian Cancer Center of The Ministry Of The Interior And Administration's Hospital, Olsztyn, Poland., Mazur G; Wroclaw Medical University, Wroclaw, Poland., Landi S; Department of Biology, University of Pisa, Pisa, Italy., Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Jerez A; Hematology and Medical Oncology Department, University Hospital Morales Meseguer, IMIB, Murcia, Spain., Norman AD; Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Hildebrandt MAT; Department of Lymphoma - Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadar K; St. John's Hospital, Budapest, Hungary., Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Ziv E; Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Buda G; Hematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Nagler A; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel., Dumontet C; INSERM 1052/CNRS 5286, CRCL, Lyon, France., Raźny M; Department of Hematology, Rydygier Specialistic Hospital, Cracow, Poland., Watek M; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Department of Hematology, Holycross Cancer Center, Kielce, Poland., Butrym A; Wroclaw Medical University, Wroclaw, Poland.; Alfred Sokolowski Specialist Hospital in Walbrzych Oncology Support Centre for Clinical Trials, Wałbrzych, Poland., Grzasko N; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland., Dudzinski M; Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland., Rybicka-Ramos M; Department of Hematology, Specialist Hospital No.1 in Bytom, Academy of Silesia, Faculty of Medicine, Katowice, Poland., Matera EL; INSERM 1052/CNRS 5286, CRCL, Lyon, France., García-Sanz R; University Hospital of Salamanca, Diagnostic Laboratory Unit in Hematology, University Hospital of Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain., Goldschmidt H; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Centre for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.; National Centre for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany. GMMG Study Group at University Hospital Heidelberg, Heidelberg, Germany., Jamroziak K; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Jurczyszyn A; Hematology Department, Jagiellonian University Medical College, Cracow, Poland., Clavero E; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain., Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Pelosini M; U.O. Dipartimento di Ematologia, Azienda USL Toscana Nord Ovest, Livorno, Italy., Zawirska D; Department of Hematology, University Hospital, Crakow, Poland., Kruszewski M; Department of Hematology, University Hospital No. 2 in Bydgoszcz, Bydgoszcz, Poland., Marques H; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Haastrup E; Department of Clinical Immunology, the Bloodbank, Rigshospitalet, Copenhagen University Hospital, København, Denmark., Sánchez-Maldonado JM; Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS, Granada, Spain.; Instituto de Investigación Biosanitaria IBs.Granada, Granada, Spain., Bertsch U; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Centre for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany., Rymko M; Department of Hematology, Provincial Polyclinical Hospital in Torun, Torun, Poland., Raab MS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Brown EE; Department of Pathology, School of Medicine at the University of Alabama, Birmingham, AL, USA., Hofmann JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Vachon C; Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Campa D; Department of Biology, University of Pisa, Pisa, Italy., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. f.canzian@dkfz.de.
Publikováno v:
Leukemia [Leukemia] 2023 Nov; Vol. 37 (11), pp. 2326-2329. Date of Electronic Publication: 2023 Sep 18.
Autor:
Dicanio M; Department of Biology, University of Pisa, Pisa, Italy., Giaccherini M; Department of Biology, University of Pisa, Pisa, Italy., Clay-Gilmour A; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Greenville, South Carolina, USA., Macauda A; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sainz J; Genomic Oncology Area, GENYO. Center for Genomics and Oncological Research: Pfizer, University of Granada/Andalusian Regional Government, Granada, Spain.; Department of Hematology, Virgen de las Nieves University Hospital, Granada, Spain.; Department of Medicine, University of Granada, Granada, Spain., Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, Maryland, USA., Rybicka-Ramos M; Department of Hematology Specialist Hospital No. 1, Bytom, Poland., Norman AD; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Ontario, USA.; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Ontario, USA., Tyczyńska A; Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, Maryland, USA., Barington T; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Kumar SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Ontario, USA., Bhatti P; Cancer Control Research, BC Cancer, Vancouver, Canada.; Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Cozen W; Division of Hematology/Oncology, Department of Medicine, School of Medicine, Susan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California, Irvine, California, USA.; Department of Pathology, School of Medicine, Susan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California, Irvine, California, USA., Brown EE; Department of Pathology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Suska A; Plasma Cell Dyscrasia Center Department of Hematology Jagiellonian University Faculty of Medicine, Kraków, Poland., Haastrup EK; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Orlowski RZ; Department of Lymphoma - Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Dudziński M; Department of Hematology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland., Garcia-Sanz R; Medina A. Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Kruszewski M; Department of Hematology, University Hospital No. 2 in Bydgoszcz, Bydgoszcz, Poland., Martinez-Lopez J; Hospital 12 de Octubre, Compluntense University, CNIO, CIBERONC, Madrid, Spain., Beider K; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel., Iskierka-Jazdzewska E; Department of Hematology, Medical University of Lodz, Łódź, Poland., Pelosini M; U.O. Dipartimento di Ematologia, Azienda USL Toscana Nord Ovest, Livorno, Italy., Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, Maryland, USA., Raźny M; Department of Hematology, Rydygier Hospital, Cracow, Poland., Jamroziak K; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Ontario, USA., Jurczyszyn A; Plasma Cell Dyscrasia Center Department of Hematology Jagiellonian University Faculty of Medicine, Kraków, Poland., Vangsted AJ; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Collado PG; Department of Hematology, Virgen de las Nieves University Hospital, Granada, Spain., Vogel U; National Research Center for the Working Environment, Copenhagen, Denmark., Hofmann JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, Maryland, USA., Petrini M; Hematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Butrym A; Department of Cancer Prevention and Therapy, Wroclaw Medical University, Wroclaw, Poland., Slager SL; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Ontario, USA., Ziv E; Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA., Subocz E; Department of Hematology, Military Institute of Medicine, Warsaw, Poland., Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Center for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Andersen NF; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Mazur G; Department of Internal Diseases, Occupational Medicine, Hypertension and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland., Watek M; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Department of Hematology, Holycross Cancer Center, Kielce, Poland., Lesueur F; Inserm, U900, Institut Curie, PSL Research University, Mines ParisTech, Paris, France., Hildebrandt MAT; Department of Lymphoma - Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zawirska D; Department of Hematology, University Hospital in Cracow, Cracow, Poland., Ebbesen LH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Marques H; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal and ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Gemignani F; Department of Biology, University of Pisa, Pisa, Italy., Dumontet C; INSERM 1052/CNRS 5286/University of Lyon, Lyon, France., Várkonyi J; Department of Hematology and Internal Medicine, Semmelweis University, Budapest, Hungary., Buda G; Hematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Nagler A; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel., Druzd-Sitek A; Department of Lymphoproliferative Diseases, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Wu X; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadar K; Department of Hematology and Internal Medicine, Semmelweis University, Budapest, Hungary., Camp NJ; Division of Hematology and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Grzasko N; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland., Waller RG; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Ontario, USA., Vachon C; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Ontario, USA., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Campa D; Department of Biology, University of Pisa, Pisa, Italy.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 Jan 15; Vol. 152 (2), pp. 239-248. Date of Electronic Publication: 2022 Oct 01.
Autor:
Macauda A; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Biology, University of Pisa, Pisa, Italy., Clay-Gilmour A; Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Greenville, South Carolina., Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Hildebrandt MAT; Department of Lymphoma - Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kruszewski M; Department of Hematology University Hospital Bydgoszcz, Bydgoszcz, Poland., Orlowski RZ; Department of Lymphoma - Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kumar SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Ziv E; Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Orciuolo E; Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy., Brown EE; Department of Pathology, School of Medicine, University of Alabama, Birmingham, Alabama., Försti A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Waller RG; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Machiela MJ; Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland., Chanock SJ; Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland., Camp NJ; Division of Hematology and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Rymko M; Department of Haematology and Bone Marrow Transplantation, SSM im. M. Kopernika, Torun, Poland., Raźny M; Department of Hematology, Rydygier Hospital, Cracow, Poland., Cozen W; Division of Hematology/Oncology, Department of Medicine, School of Medicine, Department of Pathology, School of Medicine, Susan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California at Irvine, California., Várkonyi J; Department of Hematology and Internal Medicine, Semmelweis University, Budapest, Hungary., Piredda C; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Pelosini M; Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy., Belachew AA; Department of Lymphoma - Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Subocz E; Department of Hematology, Military Institute of Medicine, Warsaw, Poland., Hemminki K; Biomedical Center, Faculty of Medicine, Charles University in Pilsen, Pilsen, Czech Republic.; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Rybicka-Ramos M; Department of Hematology Specialist Hospital No. 1 in Bytom, Bytom, Poland., Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Hofmann JN; Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland., Zaucha JM; Department of Hematology and Transplantology, Medical Univeristy of Gdańsk, Gdańsk, Poland., Vangsted AJ; Department of Haematology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark., Goldschmidt H; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany., Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Tomczak W; Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Poland., Sainz J; Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada/Andalusian Regional Government, Granada, Spain.; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain., Butrym A; Department of Internal and Occupational Diseases, Medical University Wroclaw, Wroclaw, Poland., Watek M; Hematology Clinic, Holycross Cancer Center, Kielce, Poland., Iskierka-Jazdzewska E; Department of Hematology, Medical University of Lodz, Lodz, Poland., Buda G; Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy., Robinson DP; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Jurczyszyn A; Plasma Cell Dyscrasias Center, Department of Hematology, Faculty of Medicine, Jagiellonian University, Kraków, Poland., Dudziński M; Department of Hematology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszów, Rzeszów, Poland., Martinez-Lopez J; Servicio de Hematología Centro de Actividades Ambulatorias, Madrid, Spain., Sinnwell JP; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Slager SL; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Jamroziak K; Department of Hematology, Transplantation and Internal Disease, Medical University of Warsaw, Warsaw, Poland., Reis RMV; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal and ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Weinhold N; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.; CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Bhatti P; Division of Population Oncology Cancer Control Research, BC Cancer, Vancouver, Bristish Columbia, Canada.; Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Carvajal-Carmona LG; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, California.; Latinos United for Cancer Health Advancement Initiative, University of California Davis Comprehensive Cancer Center, Sacramento, California.; Community Engagement Program, Clinical and Translational Science Center, University of California Davis, Sacramento, California., Zawirska D; Department of Hematology, University Hospital of Cracow, Cracow, Poland., Norman AD; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Mazur G; Department of Internal and Occupational Diseases, Medical University Wroclaw, Wroclaw, Poland., Berndt SI; Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland., Campa D; Department of Biology, University of Pisa, Pisa, Italy., Vachon CM; Division of Epidemiology, Department of Quantitative Sciences, Mayo Clinic, Rochester, Minnesota., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2022 Sep 02; Vol. 31 (9), pp. 1863-1866.
Autor:
Salamero O, Mart?nez-Cuadr?n D, Sobas M, Benavente C, Vives S, De la Serna J, P?rez-Encinas M, Escoda L, Gil C, Brunet S, Ramos F, Esteve J, Amigo M, Krsnik I, Manso F, Arias J, Gonz?lez-Campos J, Serrano J, Oleksiuk J, Barrios M, Garc?a-Boyero R, Novo A, Sanz M, Montesinos P, Helbig G, Holowiecka A, Armatys A, Hawrylecka D, Golos A, Ejduk A, Majcherek M, Skret A, Czyzewska J, Grosicki S, Zarzycka E, Watek M, Piatkowska-Jakubas B, Holojda J, Pluta A, Podhorecka M, Gromek T, Guzicka E, Charlinski G, Paluszewska M, de Heredia J, Hern?ndez J, Rom?n A, de la Serna J, Negri S, Ray?n C, Fern?ndez-Calvo F, D?az-Mediavilla J, Tormo M, Olave M, Amutio E, Pedro C, Gorosquieta A, Viguria M, Zudaire M, Molero T, Sayas M, Guardia R, Rivas C, Esquembre C, Garc?a R, Alcal? A, L?pez J, Rubio V, Linares M, Ribera J, San Miguel J, Deb?n G, de la C?mara R, Molines A, Loureiro C, Allegue M, Amador L, Mart? J, Madero L, Lassaletta A, Cabezudo M, Garc?a-Larana J, Rojas R, Ortega F, Pe?arrubia M, Puente F, Lopez-Ibor B, Bergua J, Ib??ez J, S?nchez P, Font L, Guinea J, Montero A, Gonz?lez M, Mart?n G, Mart?nez J, Verdeguer A, Garc?a P, Conde E, Garc?a J, Capote F, Bueno J, Bastida P, Rubio A, Fuster J, Gonz?lez J, P?rez I, Molina J, Mateos M, Ardaiz M, Rodr?guez-Calvillo M, Poder?s C, Arn?n M, Duarte R, D?az-Morfa M, Mart?n-Chac?n E, Calvo-Villas J, Garc?a-Belmonte D, Hern?ndez-Maraver D, Miskiewicz W, PETHEMA Grp, PALG Grp
Publikováno v:
LEUKEMIA & LYMPHOMA
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Acute promyelocytic leukemia is infrequent among patients aged >= 75 years old, a population that is rarely eligible for clinical protocols. This study aims to analyze the treatment strategies and clinical outcomes of very old APL patients reported t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::18d09b23d62783b6990f1f5f2c18ad0e
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7288
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7288
Autor:
Sobas M, Montesinos P, Boluda B, Bernal T, Vellenga E, Nomdedeu J, Gonzalez-Campos J, Chillon M, Holowiecka A, Esteve J, Bergua J, Gonzalez-Sanmiguel J, Gil-Cortes C, Tormo M, Salamero O, Manso F, Fernandez I, de la Serna J, Moreno M, Perez-Encinas M, Krsnik I, Ribera J, Escoda L, Lowenberg B, Sanz M, de Heredia J, Hernandez J, Arias J, Ramos F, Roman A, Negri S, Rayon C, Fernandez-Calvo F, Diaz-Mediavilla J, Gil C, Olave M, Amutio E, Pedro C, Gorosquieta A, Viguria M, Zudaire M, Molero T, Sayas M, Guardia R, Esquembre C, Garcia R, Alcala A, Lopez J, Rubio V, Amigo M, Linares M, San Miguel J, Coruna A, Deben G, de la Camara R, Molines A, Loureiro C, Allegue M, Amador L, Marti J, Madero L, Lassaletta A, Cabezudo M, Garcia-Larana J, Rojas R, Ortega F, Penarrubia M, Puente F, Lopez-Ibor B, Brunet S, Ibanez J, Sanchez P, Novo A, Guinea J, Montero A, Gonzalez M, Martin G, Martinez J, Verdeguer A, Garcia P, Conde E, Garcia J, Capote F, Bueno J, Bastida P, Rubio A, Fuster J, Gonzalez J, Perez I, Molina J, Mateos M, Ardaiz M, Rodriguez-calvillo M, Poderos C, Arnan M, Duarte R, Diaz-Morfa M, Martin-Chacon E, Calvo-Villas J, Garcia-Belmonte D, Hernandez-Maraver D, Ossenkoppele G, van der Lelie J, Sonneveld P, Zijlmans M, Maertens J, de Valk B, Wijermans P, de Groot M, Schouten H, Biesma D, van Marwijk M, de Lisa E, Golos A, Ejduk A, Armatys A, Zarzycka E, Knopinska W, Miskiewicz W, Jastrzab B, Pluta A, Paluszewska M, Podhorecka M, Gromek T, Jakubas B, Majcherek M, Skret A, Watek M, Charlinski G, Calbecka M, Becht R, Gadomska A, Rzenno E, Piszcz J, Grosicki S, Palmer L, Ciarlo S, Bezares F, Rojas F, Longoni H, Gelemur M, Fazio P, Canepa C, Saba S, Balladares G, Negri P, Giunta M, Milone J, Lafalse D, Sossa C, Jaramillo F, Mayer J, Protivankova M, Scwarz J, PETHEMA Cooperative Grp, HOVON Cooperative Grp, PALG Cooperative Grp, GATLA Cooperative Grp
Publikováno v:
LEUKEMIA & LYMPHOMA
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Out of 956, there were 95 (10%) CD56+ APL patients treated with PETHEMA ATRA and chemotherapy. CD56+ expression was associated with high WBC, BCR3 isoform, and co-expression of CD2, CD34, CD7, HLA-DR, CD15, and CD117 antigens. CD56+ vs CD56- APL pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::2899368e79ad54c038cc13c56e7f32b6
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8035
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8035
Autor:
Labrador J, Luno E, Vellenga E, Brunet S, Gonzalez-Campose J, Chillon M, Holowiecka A, Esteve J, Bergua J, Gonzalez-Sanmiguel J, Gil C, Tormo M, Salamero O, Manso F, Fernandez I, de laSerna J, Moreno M, Perez-Encinas M, Krsnik I, Ribera J, Cervera J, Calasanz M, Boluda B, Sobas M, Lowenberg B, Sanz M, Montesinos P, Palmer L, Ciarlo S, Bezares F, Rojas F, Longoni H, Gelemur M, Fazio P, Canepa C, Saba S, Balladares G, Negri P, Giunta M, Milone J, Prates M, Lafalse D, Sossa C, Jaramillo F, Mayer J, Protivankova M, Scwarz J, Holowiecka-Goral A, Jakubas B, Skret-Norwicz A, Bizgalska-Skrzypek P, Pluta A, Becht R, Kielbinski M, Watek M, Paluszewska M, Gadomska A, Rzenno E, Piszcz J, Ejduk A, Dobrzanska J, Calbecka M, Kostyra A, Malek M, Grosicki S, Knopinska W, Beltran de Heredia J, Hernandez J, Arias J, Ramos F, Roman A, de la Serna J, Negri S, Rayon C, Fernandez-Calvo F, Diaz-Mediavilla J, Olave M, Amutio E, Pedro C, Gorosquieta A, Viguria M, Zudaire M, Molero T, Sayas M, Guardia R, Rivas C, Esquembre C, Garcia R, Alcala A, Lopez J, Rubio V, Amigo M, Linares M, Gonzalez San Miguel J, Deben G, Escoda L, de la Camara R, Molines A, Loureiro C, Allegue M, Amador L, Marti J, Madero L, Lassaletta A, Cabezudo M, Garcia-Larana J, Rojas R, Ortega F, Penarrubia M, Puente F, Lopez-Ibor B, Ibanez J, Sanchez P, Novo A, Font L, Guinea J, Montero A, Gonzalez M, Martin G, Martinez J, Verdeguer A, Garcia P, Conde E, Garcia J, Capote F, Bueno J, Bastida P, Rubio A, Fuster J, Gonzalez J, Perez I, Molina J, Mateos M, Ardaiz M, Rodriguez-calvillo M, Poderos C, Arnan M, Duarte R, Diaz-Morfa M, Martin-Chacon E, Calvo-Villas J, Garcia-Belmonte D, Hernandez-Maraver D, Ossenkoppele G, van der Lelie J, Sonneveld P, Zijlmans M, Maertens J, de Valk B, Wijermans P, de Groot M, Schouten H, Biesma D, Kooy M, de Lisa E, PETHEMA Grp, HOVON Grp, PALG Grp, GATLA Grp
Publikováno v:
Leukemia & lymphoma
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA & LYMPHOMA
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Leukemia & Lymphoma
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA & LYMPHOMA
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Leukemia & Lymphoma
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
Although additional cytogenetic abnormalities (ACA) do not affect the prognosis of patients with t(15;17) acute promyelocytic leukemia (APL), the role of a complex karyotype (CK) is yet to be clarified. We aimed to investigate the relationship of CK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4d8f98dfbba4745776336cc5815100f5
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10070
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10070
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Melaiu O; Department of Biology, University of Pisa, Pisa, Italy., Macauda A; Department of Biology, University of Pisa, Pisa, Italy.; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sainz J; Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Department of Medicine, University of Granada, Granada, Spain., Calvetti D; Department of Biology, University of Pisa, Pisa, Italy.; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Facioni MS; Department of Biology, University of Pisa, Pisa, Italy., Maccari G; The Pirbright Institute, Pirbright, Surrey, UK., Ter Horst R; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands., Netea MG; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.; Department for Immunology and Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany., Li Y; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Grząśko N; Hematology Department, St. John's Cancer, Lublin, Poland., Moreno V; Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), IDIBELL, CIBERESP and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona. Hospitalet de Llobregat, Barcelona, Spain., Jurczyszyn A; Department of Hematology, Cracow University Hospital, Cracow, Poland., Jerez A; Hematology and Medical Oncology Department, University Hospital Morales Meseguer, IMIB, Murcia, Spain., Watek M; Holycross Medical Center, Kielce, Poland., Varkonyi J; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary., Garcia-Sanz R; Department of Hematology, University Hospital of Salamanca, Instituto de Investigación Biomédica de Salamanca, IBSAL, Salamanca, Spain., Kruszewski M; Department of Hematology, University Hospital, Bydgoszcz, Poland., Dudziński M; Department of Hematology, Specialist District Hospital, Rzeszow, Poland., Kadar K; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary., Jacobsen SEH; Clinic of Immunology, Laboratory Center, Hospital of Southern Jutland, Sønderborg, Denmark., Mazur G; Department of Internal Diseases, Hypertension and Occupational Medicine, Medical University, Wroclaw, Poland., Andersen V; Research Unit of Molecular Diagnostics and Clinical Research, Laboratory Center, Hospital of Southern Jutland, Aabenraa, Denmark.; Institute of Regional Health Research, and Institute of Molecular Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark., Rybicka M; Department of Hematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland., Zawirska D; Department of Hematology, Cracow University Hospital, Cracow, Poland., Raźny M; Department of Hematology, Rydygier Hospital, Cracow, Poland., Zaucha JM; Department of Hematology, Sea Hospital, Gdynia, Poland., Ostrovsky O; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel., Iskierka-Jazdzewska E; Department of Hematology, Medical University of Lodz, Lodz, Poland., Reis RM; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Stępień A; Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, Lodz, Poland., Beider K; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel., Nagler A; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel., Druzd-Sitek A; Department of Lymphoid Malignancies, Maria Sklodowska-Curie Memorial Institute and Oncology Centre Warsaw, Warsaw, Poland., Marques H; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Martìnez-Lopez J; Department of Hematology, Hospital Universitario 12 de Octubre, Complutense School of Medicine, CNIO, Madrid, Spain., Lesueur F; Institut Curie, Paris, France.; PSL Research University, Paris, France.; Inserm, Paris, France.; Mines Paris Tech, Fontainebleau, France., Avet-Loiseau H; Hematology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Vangsted AJ; Department of Haematology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark., Krawczyk-Kulis M; Department of Hematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland., Butrym A; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University, Wrocław, Poland., Jamroziak K; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Dumontet C; Université Claude Bernard Lyon I, Lyon, France., Vogel U; National Research Centre for the Working Environment, Copenhagen, Denmark., Rymko M; Department of Hematology, Copernicus Hospital, Torun, Poland., Pelosini M; U.O. Dipartimentale di Ematologia, Azienda USL Toscana Nord Ovest, Livorno, Italy., Subocz E; Department of Hematology, Military Institute of Medicine, Warsaw, Poland., Szombath G; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary., Sarasquete ME; Department of Hematology, University Hospital of Salamanca, Instituto de Investigación Biomédica de Salamanca, IBSAL, Salamanca, Spain., Silvestri R; Department of Biology, University of Pisa, Pisa, Italy., Morani F; Department of Biology, University of Pisa, Pisa, Italy., Landi S; Department of Biology, University of Pisa, Pisa, Italy., Campa D; Department of Biology, University of Pisa, Pisa, Italy., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Gemignani F; Department of Biology, University of Pisa, Pisa, Italy.
Publikováno v:
International journal of cancer [Int J Cancer] 2021 Apr 15; Vol. 148 (8), pp. 1887-1894. Date of Electronic Publication: 2020 Nov 20.
Autor:
Giaccherini M; Department of Biology, University of Pisa, Pisa, Italy., Macauda A; Department of Biology, University of Pisa, Pisa, Italy.; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Orciuolo E; Haematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Rymko M; Department of Hematology, Copernicus Hospital, Torun, Poland., Gruenpeter K; Department of Haematology and Bone Marrow Transplantation, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland., Dumontet C; Hospices Civils de Lyon, Lyon, France., Raźny M; Department of Hematology, Rydygier Specialistic Hospital, Cracow, Poland., Moreno V; Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), IDIBELL, CIBERESP and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain., Buda G; Haematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Beider K; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel., Varkonyi J; Semmelweis University, Budapest, Hungary., Avet-Loiseau H; Laboratory for Genomics in Myeloma, Institut Universitaire du Cancer and University Hospital, Centre de Recherche en Cancerologie de Toulouse, Toulouse, France., Martinez-Lopez J; Hospital 12 de Octubre, Complentese University, CNIO, CIBERONC, Madrid, Spain., Marques H; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal and ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Watek M; Department of Hematology, Holy Cross Cancer Center, Kielce, Poland.; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Sarasquete ME; Hematology Department, University Hospital of Salamanca, CIBERONC, Salamanca, Spain., Andersen V; Department of Biochemistry, University Hospital of Southern Jutland, Sønderborg, Denmark.; IRS-Center Soenderjylland, University Hospital of Southern Jutland, Aabenraa, Denmark., Karlin L; Hospices Civils de Lyon, Lyon, France., Suska A; Department of Hematology, Jagiellonian University Medical College, Krakow, Poland., Kruszewski M; Department of Hematology, University Hospital No. 2 in Bydgoszcz, Bydgoszcz, Poland., Abildgaard N; Department of Hematology, Odense University Hospital, Odense, Denmark., Dudziński M; Department of Hematology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland., Butrym A; Department of Internal Diseases, Occupational Medicine, Hypertension and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland., Nagler A; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel., Vangsted AJ; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Kadar K; Semmelweis University, Budapest, Hungary., Waldemar T; Department of Haemato-oncology and Bone Marrow Transplantation and Department of Internal Medicine in Nursing, Medical University of Lublin, Lublin, Poland., Jamroziak K; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Jacobsen SEH; Department of Biochemistry, University Hospital of Southern Jutland, Sønderborg, Denmark., Ebbesen LH; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Taszner M; Department of Hematology and Transplantology Medical University of Gdansk, Gdańsk, Poland., Mazur G; Department of Internal Diseases, Occupational Medicine, Hypertension and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland., Lesueur F; Inserm, U900, Institut Curie, PSL University, Mines ParisTech, Paris, France., Pelosini M; U.O. Dipartimento di Ematologia, Azienda USL Toscana Nord Ovest, Livorno, Italy, currently Ospedale Santa Chiara, Pisa, Italy., Garcia-Sanz R; Hematology Department, University Hospital of Salamanca, CIBERONC, Salamanca, Spain., Jurczyszyn A; Department of Hematology, Jagiellonian University Medical College, Krakow, Poland., Demangel D; Hospices Civils de Lyon, Lyon, France., Reis RM; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal and ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Iskierka-Jażdżewska E; Department of Hematology, Medical University of Lodz, Łódź, Poland., Markiewicz M; Department of Hematology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland., Gemignani F; Department of Biology, University of Pisa, Pisa, Italy., Subocz E; Department of Hematology, Military Institute of Medicine, Warsaw, Poland., Zawirska D; Department of Haematology, University Hospital in Cracow, Cracow, Poland., Druzd-Sitek A; Department of Lymphoid Malignancies, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Stępień A; Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, Łódź, Poland., Alonso MH; Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), IDIBELL, CIBERESP and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain., Sainz J; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. f.canzian@dkfz.de., Campa D; Department of Biology, University of Pisa, Pisa, Italy.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2021 Apr 14; Vol. 11 (4), pp. 74. Date of Electronic Publication: 2021 Apr 14.
Autor:
Singh, Aman1 (AUTHOR) asing945@uwo.ca, Ravendranathan, Naresh1 (AUTHOR) nravendr@uwo.ca, Frisbee, Jefferson C.1 (AUTHOR) jfrisbee@uwo.ca, Singh, Krishna K.1,2 (AUTHOR) krishna.singh@uwo.ca
Publikováno v:
Biomolecules (2218-273X). Aug2024, Vol. 14 Issue 8, p922. 27p.